标题
Emerging strategies for the treatment of older patients with acute myeloid leukemia
作者
关键词
Acute myeloid leukemia, Older patients, Novel agents, Low-intensity therapy, Targeted therapy
出版物
ANNALS OF HEMATOLOGY
Volume 95, Issue 10, Pages 1583-1593
出版商
Springer Nature
发表日期
2016-04-27
DOI
10.1007/s00277-016-2666-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia
- (2015) M. Dennis et al. BLOOD
- International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
- (2015) H. Dombret et al. BLOOD
- Progress in Acute Myeloid Leukemia
- (2015) Tapan M. Kadia et al. Clinical Lymphoma Myeloma & Leukemia
- Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
- (2015) Farhad Ravandi et al. LANCET ONCOLOGY
- A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia
- (2015) A K Burnett et al. LEUKEMIA
- Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
- (2014) Sarah A. Buckley et al. AMERICAN JOURNAL OF HEMATOLOGY
- Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
- (2014) Margriet Oosterveld et al. ANNALS OF HEMATOLOGY
- Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2014) Lisa Pleyer et al. ANNALS OF HEMATOLOGY
- Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
- (2014) J. E. Lancet et al. BLOOD
- Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
- (2014) H. Dohner et al. BLOOD
- REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia
- (2014) Robert K. Stuart et al. BRITISH JOURNAL OF HAEMATOLOGY
- Advances in the treatment of elderly and frail patients with acute myeloid leukemia
- (2014) Sergio Amadori et al. CURRENT OPINION IN ONCOLOGY
- Volasertib for the treatment of acute myeloid leukemia: a review of preclinical and clinical development
- (2014) Melanie Janning et al. Future Oncology
- A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia
- (2014) J. E. Lancet et al. HAEMATOLOGICA
- Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia
- (2014) Friederike Pastore et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of elderlyde novoacute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status
- (2013) Jae-Ho Yoon et al. AMERICAN JOURNAL OF HEMATOLOGY
- Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia
- (2013) Aziz Nazha et al. AMERICAN JOURNAL OF HEMATOLOGY
- Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia
- (2013) David Martínez-Cuadrón et al. ANNALS OF HEMATOLOGY
- Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
- (2013) Hagop M. Kantarjian et al. CANCER
- Vosaroxin: a new valuable tool with the potential to replace anthracyclines in the treatment of AML?
- (2013) Ciara Freeman et al. EXPERT OPINION ON PHARMACOTHERAPY
- Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial
- (2013) Hubert Serve et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
- (2013) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
- (2012) R. Fruscio et al. ANNALS OF ONCOLOGY
- Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia
- (2012) A. Quintas-Cardama et al. BLOOD
- Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure
- (2012) S-H Shin et al. BONE MARROW TRANSPLANTATION
- Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study
- (2012) Jerzy Holowiecki et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study
- (2012) Hagop Kantarjian et al. LANCET ONCOLOGY
- Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia
- (2012) Ellen K. Ritchie et al. LEUKEMIA & LYMPHOMA
- Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
- (2011) M. Levis et al. BLOOD
- Acute myeloid leukaemia in the elderly: a review
- (2011) Daniel A. Pollyea et al. BRITISH JOURNAL OF HAEMATOLOGY
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
- (2010) H. Kantarjian et al. BLOOD
- A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial
- (2010) C. Rollig et al. BLOOD
- Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome
- (2010) Celeste Bello et al. CANCER
- Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS
- (2010) Arnaud Pigneux et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- (2010) Thomas Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes
- (2010) Utz Krug et al. LANCET
- Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts
- (2010) Wah-Seng Lim et al. LEUKEMIA RESEARCH
- Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
- (2010) W. Blum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
- (2009) P. P. Zarrinkar et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse
- (2009) F. Giles et al. BLOOD
- A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
- (2009) J.-L. Harousseau et al. BLOOD
- Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials
- (2009) Keith Wheatley et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in Elderly acute myeloid leukaemia patients
- (2009) Massimo Breccia et al. HEMATOLOGICAL ONCOLOGY
- Single-Agent Laromustine, A Novel Alkylating Agent, Has Significant Activity in Older Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia
- (2009) Gary J. Schiller et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
- (2009) Amanda F. Cashen et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
- (2009) Bob Löwenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
- (2008) G. Juliusson et al. BLOOD
- A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2008) S. Faderl et al. BLOOD
- Clofarabine combinations as acute myeloid leukemia salvage therapy
- (2008) Stefan Faderl et al. CANCER
- Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models
- (2008) Ute Hoch et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II Trial of Tipifarnib as Maintenance Therapy in First Complete Remission in Adults with Acute Myelogenous Leukemia and Poor-Risk Features
- (2008) J. E. Karp et al. CLINICAL CANCER RESEARCH
- Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia
- (2008) J.-V. Malfuson et al. HAEMATOLOGICA
- Current and Emerging Strategies for the Management of Acute Myeloid Leukemia in the Elderly
- (2008) J. Laubach et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now